Benidipine hydrochloride

CAS No. 91599-74-5

Benidipine hydrochloride( (±)-Benidipine | KW-3049 )

Catalog No. M16577 CAS No. 91599-74-5

Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
50MG 28 In Stock
100MG 37 In Stock
200MG 52 In Stock
500MG 86 In Stock
1G 124 In Stock

Biological Information

  • Product Name
    Benidipine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
  • Description
    Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
  • In Vitro
    Western Blot Analysis Cell Line:Murine PBMCs Concentration:1 μM Incubation Time:7 days Result:Increased the expression of phosphorylated Akt on serine-473.Cell Proliferation Assay Cell Line:Mesangial cells Concentration:0.1-10 μM Incubation Time:48 h Result:Inhibited the progression of the cell cycle in a dose-dependent manner.
  • In Vivo
    Animal Model:MI/R rabbits model Dosage: 3-10 μg/kg Administration:i.v.Result:Caused a significant decrease in HR ( heart rate), MABP (mean arterial blood pressure), and PRI (pressure-rate index) at 10 μg/kg.Decreased apoptotic positive cells to 7.4% at 3 μg/kg.Animal Model:Renovascular hypertensive rats (RHR) model Dosage:5 mg/kg Administration:i.v.Result:Decreased the blood pressure and coronary vascular resistance index.Increased nitrite production and eNOS mRNA expression and the coronary flow at rest, the capillary density.Animal Model:Rat heart model Dosage:1-10 mg/kg Administration:p.o.Result:Increased the post-ischemic recovery of LVDP and LV dP/dt max (LVDP: 87.5±10.1 vs 64.6±11.9%;LV dP/dt max: 97.8±10.4 vs 70.2±15.7%) at 3 mg/kg.
  • Synonyms
    (±)-Benidipine | KW-3049
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR (L861Q)| c-Src| c-Yes| Lck| Lyn
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    91599-74-5
  • Formula Weight
    542.03
  • Molecular Formula
    C27H32ClN5O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 8 mg/mL (14.75 mM)
  • SMILES
    CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chang YM, Oncogene, 2008, 27(49), 6365-6375.
molnova catalog
related products
  • EGFR/ErbB2 Inhibitor

    EGFR/ErbB2 Inhibitor is a cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, respectively)

  • Lapatinib ditosylate

    A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.

  • CP-380736

    CP-380736 is an epidermal growth factor receptor (EGFR) inhibitor. EGFR is a tyrosine kinase that activates MAPK, JNK, and Akt pathways, and is an important mediator of several types of cancer.